Skip to main content

Hereditary Multiple Osteochondromas clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • An Efficacy and Safety Study of Palovarotene for the Treatment of MO

    Sorry, in progress, not accepting new patients

    This is a randomized, double-blind, placebo-controlled study comparing the safety and efficacy of 2 dosage regimens of palovarotene versus placebo in preventing disease progression in pediatric subjects with multiple osteochondromas (MO).

    San Francisco, California and other locations

Last updated: